ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
73.60
Bid
73.60
Offer
73.65
Volume
5,552
72.90 Day's Range 73.70
0.00 52 Week Range 0.00
Previous Close
72.65
Open
72.90
Last Trade
35
@
73.6
Last Trade Time
00:35:02
Average Volume (3m)
-
Financial Volume
407,190 €
VWAP
73.3412

SWP Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

SWP - Frequently Asked Questions (FAQ)

What is the current Sodexo share price?
The current share price of Sodexo is 73.60 €
What is the 1 year trading range for Sodexo share price?
Sodexo has traded in the range of 0.00 € to 0.00 € during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PRSOProSafe SE
kr 12.34
(71.63%)
288
BIOBVHBiohit Oyj B
2.96 €
(39.62%)
6
SOSI1HSotkamo Silver AB
0.105 €
(21.25%)
4.29k
DBVPDBV Technologies
0.839 €
(17.18%)
47.26k
ALCBXPCibox Interactive
0.0392 €
(15.98%)
4.38k
XXLOXXL ASA
kr 17.998
(-20.15%)
16
LBRADAmundi MSCI Brazil UCITS ETF Acc
16.942 €
(-9.27%)
539
PRECSPrecise Biometrics AB
SEK 5.13
(-8.88%)
6.29k
HLAGDHapag-Lloyd AG
144.60 €
(-7.66%)
714
QECOQuesterre Energy Corporation
kr 1.794
(-6.95%)
3.78k
ATOPAtos SE
0.002 €
(-4.76%)
203.13M
FINGBSFingerprint Cards AB
SEK 0.0448
(7.43%)
3.89M
TITMTelecom Italia SpA
0.2572 €
(-0.16%)
3.7M
BCPUBanco Comercial Portugues SA
0.47615 €
(-2.01%)
1.51M
CABKECaixaBank SA
5.60 €
(3.21%)
1.24M

Discussion

View Full Feed
Buckey Buckey 3 minutes ago
WTF are you serious? you buy insurance as a protection. This absolutely must be illegal. I can see them cancelling before an event but not in the middle
Invest-in-America Invest-in-America 4 minutes ago
BAER: Heck, it would be very EFFICIENT & otherwise COST-EFFECTIVE for investors, Wall Street, & ALL of America --- if all THREE of them croaked or got ASSASSINATED on the SAME DAY !!!

https://i.giphy.com/media/v1.Y2lkPTc5MGI3NjExMGF0c3gxam54ODhna3d3cHA5Mzdzb3dpdXBpNjE0MGJkcXo
BAER
ImjinBridger ImjinBridger 4 minutes ago
I think you had better say that KBLB is going to rocket within the next several months not two years.
Say what want Chi. You can find that exact same prediction from him at least a couple times a week for the last 15 years.
KBLB
tw0122 tw0122 4 minutes ago
REVG not REVB
REVB
TMaga TMaga 5 minutes ago
We need facts not hype. Every single OTC gives you hype everyday and they continue to do it right up to when the Fat Lady is clearing her throat for her one song concert.
ADHC
TrendTrade2016 TrendTrade2016 5 minutes ago
Natural gas plays in 2025 will offer great trading opportunities, and Trumps drill baby drill policy will work against oil producing stocks, but pipelines and natural gas stocks will be the place to be, especially Canadian natural gas producers, now that Trudeau is gone.Canadian Gas producers are ve
tw0122 tw0122 5 minutes ago
True that folks living to 100 no problem now adays the next group will go to 120 with medical advances lol. Then next they will start reviving the frozen brains and bodies of celebrities like M Jackson woo hoo 
Bigger firefight related caps REVB no board and WLDN might see smaller firefight b
REVB WLDN
Guzzi62 Guzzi62 6 minutes ago
https://www.anavex.com/post/anavex-life-sciences-announces-expansion-of-leadership-team
AVXL
Gmenfan Gmenfan 7 minutes ago
Stay warm down there! It was 15° when I took the dogs out this morning. The wind chill was -2°. The dogs and I didn't spent much time out there.
Joe Kaplan Joe Kaplan 7 minutes ago
re silver shortage.......and demand/supply imbalance
Silver's Perfect Storm: 200M oz Deficit, M&A Wave & 2025 Price Targets | Peter Krauth

https://www.youtube.com/watch?v=vSm4HlP5FZI&t=6s
PAAS
Hosai Hosai 8 minutes ago
It was a misunderstanding as he's never updated his linked in to show works at Anavex plus they noticed his position was open on anavex jobs page but that page hasn't been updated in ages (since before he filled the vacancy).
AVXL
georgejjl georgejjl 8 minutes ago
https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.090729
AVXL
Filterthenoise Filterthenoise 9 minutes ago
Fraud azz reaching deep into the bag of desperation on the market holiday🎅
RNVA
WeTheMarket WeTheMarket 9 minutes ago
Repost from Stocktwits board, courtesy of B_B_

https://www.energy.gov/lpo/nepa-related-public-involvement

https://www.energy.gov/lpo/ea-2281-draft-environmental-assessment-limestone-green-hydrogen-production-project

https://www.energy.gov/sites/default/fi
PLUG
Filterthenoise Filterthenoise 9 minutes ago
Did a key word search for "moving" Nothing showed up🎅
RNVA
Zadie420 Zadie420 9 minutes ago
What is the competition price? If you have a link to that report i greatly appreciate it. Keep in mind that CKPT got approval based on efficacy not financial cost. At the end survival is more important than the price of medicine. I am very surprised with CEO not addressing this issue.
CKPT
TrendTrade2016 TrendTrade2016 10 minutes ago
Warren Buffet has declared there is nowhere to invest at this time, except the oil and gas sector.
dewophile dewophile 10 minutes ago
RSV market opportunity:

1. The FDA this week mandated that both RSV adult vaccines carry a warning for GBS based on recently updated surveillance data showing an increase in GBS cases for both vaccines (it was something like 9 cases per million for PFE and 7 for GSK). GSK uses a lower
ENTA PFE
Investor2014 Investor2014 10 minutes ago
According to his LinkedIn profile he has never worked for Anavex - that is unless there is more than one MD PhD with that name and not on LinkedIn.

https://www.linkedin.com/in/juan-carlos-lopez-talavera-md-phd-632b924/
AVXL
Hosai Hosai 13 minutes ago
With an OLE there can't in a sense be a standard stat sig finding as there is no placebo control, you can have stat sig against ADNI but obv that would be not as robust as proper placebo controlled trial. Look at all the arguments against Cassava in regards to their open label data. However clearly
AVXL
marcis marcis 13 minutes ago
Again wrong. You projecting an opinion and incomplete information as fact once again for a negative agenda.

“bad bet” Since you don’t trade with that kind of capital, why should anyone listen to you?

Most likely the $100,000 trade buy was not a bet.
It’s rare to
RDAR

Your Recent History

Delayed Upgrade Clock